16
Event Line
Swiss competition watchdog probes Novartis over patent use
Novartis says it is subject of Swiss competition probe
Federal judge dismisses kickback claims in Novartis whistleblower case — again
With fresh $160M, RayzeBio plots sprint through the clinic for lead radiopharmaceutical program — building on Novartis success
Novartis to make $300m investment in next-generation biotherapeutics
Novartis and BeiGene announce positive phase 3 trial results for hepatocellular carcinoma treatment
Novartis invests in early technical development capabilities for next-generation biotherapeutics
Novartis funnels $300M into early biologic drug manufacturing
Novartis to invest $300mn in European biotherapeutics
In the middle of an R&D shakeup, Novartis makes a $300M investment in early-stage biologics research tech
2026-09-27
Related Topic
# Novartis
Company Market Cap
novartis
NVS
145.51 USD
